Community-reported Arcalion side effects:
none 2008-08-08 12:39:48
nausea 2008-08-21 08:23:52
Add Your Side Effect to the Community Database
Help Community - Describe Your Arcalion Side Effect Episode
Have You dealt with a Arcalion side effect? Share your experience
Review Arcalion Safety Reports submitted to FDA
Total Arcalion reports: 3.Arcalion FDA safety alerts: No.
Reported hospitalizations: 3.
Take Arcalion Side Effects Survey, Discuss Arcalion with others
FDA Reported Arcalion Side Effects: dermatitis bullous, rash erythematous, pruritus, lupus-like syndrome, loss of consciousness, injury, fall, erythema multiforme, epidermolysis, dehydration, conjunctivitis.
More About Arcalion.
If you have questions about Arcalion, you can ask a Health Expert or Ask Patient Community about Arcalion.
Arcalion Side Effects Report #5259647-5
Consumer or non-health professional from FRANCE reported ARCALION problem on Mar 05, 2007. Female patient, 79 years of age, was treated with ARCALION. After drug was administered, patient experienced the following problems/side effects: dermatitis bullous, fall, injury, loss of consciousness, lupus-like syndrome, pruritus, rash erythematous, sjogren's syndrome, stevens-johnson syndrome. ARCALION dosage: unknown. During the same period patient was treated with PRIMPERAN, TRIFLUCAN, DESLORATADINE, ESIDRIX. Patient was hospitalized. Patient recovered.
Arcalion Side Effects Report #5293079-9
ARCALION problem was reported by a Consumer or non-health professional from FRANCE on Apr 04, 2007. Female patient, 79 years of age, was treated with ARCALION. After drug was administered, patient experienced the following problems/side effects: dermatitis bullous, fall, injury, loss of consciousness, lupus-like syndrome, proteinuria, pruritus, rash erythematous, renal failure acute. ARCALION dosage: unknown. During the same period patient was treated with PRIMPERAN, TRIFLUCAN, DESLORATADINE, ESIDRIX. Patient was hospitalized. Patient recovered.
Arcalion Side Effects Report #5336784-8
Consumer or non-health professional from FRANCE reported ARCALION problem on May 22, 2007. Female patient, 79 years of age, was diagnosed with depressive symptom and was treated with ARCALION. After drug was administered, patient experienced the following problems/side effects: anti-ss-a antibody positive, antinuclear antibody positive, blood uric acid increased, c-reactive protein increased, conjunctivitis, dehydration, dermatitis bullous, epidermolysis, erythema multiforme. ARCALION dosage: unknown. During the same period patient was treated with PRIMPERAN, TRIFLUCAN, DESLORATADINE, ESIDRIX. Patient was hospitalized. Patient recovered.
Ask Our Patient Community about Arcalion |
||
|
|
||
|
|
||
